High expression of RGS1, RGS2 and RGS3 in patients with gastric cancer has been shown to be associated with poor prognosis or poor tumor stage (Wang et al., 2017; Li S. et al., 2021; Yang et al., 2022). This evidence concerns the gene RGS2 and neoplasm.